JPMorgan Double Upgrades Clorox (CLX) to Overweight; Sees Upside to Estimates on COVID-19 Demand
Go back to JPMorgan Double Upgrades Clorox (CLX) to Overweight; Sees Upside to Estimates on COVID-19 Demand| The Clorox Company (NYSE: CLX) | Delayed: 86.40 -2.26 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.66 | 52 Week High | $140.47 | |||
| Open | $87.71 | 52 Week Low | $111.24 | |||
| Day High | $88.36 | P/E | 20.14 | |||
| Day Low | $85.87 | EPS | $4.29 | |||
| Volume | 1,977,482 | |||||



